References
Белоконь, Н.А. Болезни сердца и сосудов у детей: руководство для врачей / Н.А. Белоконь, М.Б. Кубергер. - В 2 т. - Т. 1. - М.: Медицина, 1987.-448 с.
Бокерия, Л.А. Риск внезапной сердечной смерти у больных гипертрофической кардиомиопатией / Л.А. Бокерия, К.В. Борисов, Е.Д. Савченко // Грудная и серд.-сосуд. хир. - 1998. - № 2. - С. 62-66.
Бокерия, Л.А. Оригинальный способ хирургического лечения гипертрофической обструктивной кардиомиопатии / Л.А. Бокерия, К.В. Борисов, А.Ф. Синев // Там же. - С. 4-10.
Бухарин, В.Ф. Клиника, диагностика и лечение идиопатического субаортального стеноза / В.Ф. Бухарин, Ю.С. Петросян, М.А. Иваницкая и др. // Кардиология. - 1975. - № 3. - С. 23-30.
Габрусенко, С.А. Сравнительная оценка различных вариантов длительного медикаментозного лечения больных гипертрофической кардиомиопатией / С.А. Габрусенко, Н.В. Аверкина, Т.А. Малкина и др. // 3-я Междунар. научная конф. "Лечение кардиомиопатии": тезисы докл. - М., 30-31 мая 2003 г. - С. 48.
Гуревич, М.А. Принципы консервативной терапии гипертрофической кардиоимиопатии / М.А. Гуревич // Консилиум-медикум. - 2001. - Т. 1, № 10.
Джанашия, П.X. Кардиомиопатии и миокардиты / П.X. Джанашия, В.А. Круглов, В.А. Назаренко, С.А. Николенко. - М.: РГМУ, 2000. - С. 112.
Доклад Комитета экспертов ВОЗ "Кардиомиопатии". - Женева, 1990. - С. 67.
Коровина, Е.П. Гипертрофическая кардиомиопатия. Клинико-диагностические особенности морфометрических вариантов / Е.П. Коровина: автореф. дис.... канд. мед. наук. - М., 1988.
Лилли, Л. Патофизиология заболеваний сердечно-сосудистой системы / Л. Лилли. - М.: Бином. Лаборатория знаний, 2003. - С. 305-327.
Оводова, Н.Ф. Обструктивная гипертрофическая кардиомиопатия (клиника, диагностика, лечение) / Н.Ф. Оводова: автореф. дис. ... д-ра мед. наук. - М., 1984.
Поляков, В.П. Кардиологическая практика: руководство для врачей / В.П. Поляков, Б.Л. Мовшович, Г.Г. Савельева. - В 2 т. - Самара, 1993.-Т. 2.
Abchee, A. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy / A. Abchee, A.J. Marian // J. Investig. Med. - 1997. - Vol. 45, № 4. - P. 191-196.
American College of Cardiology / European Society of Cardiology Clinical Expert Document of Hypertrophic Cardiomyopathy // J. Amer. Coll. Cardiol. - 2003. - Vol. 42, № 9.
Blair, E. Mutations in the gamma (2) submit, of AMP-activated proteinkinase cause familial g.c.: evidence for the central role of energy compromise in disease pathogenesis / E. Blair, C. Redwood, H. Ashrafian et al. // Hum. Mol. Genet. - 2001. - Vol. 10.-P. 1215-1220.
Bonow, R.O. Regional left ventricular asynchrony and impaired global ventricular filling in hypertrophic cardiomyopathy: effect of verapamil / R.O. Bonow, D.P. Vitale, B.J. Maron et al. // J. Amer. Coll. Cardiol.- 1987. - Vol. 9. - P. 1108-1116.
Camerini, F. Advances in cardiomyopathies / F. Camerini, A. Gavacci, R. De Maria. - Milano: Springer - Verlad, 1998. - P. 72-76.
Casanova, M. Familial hypertrophic cardiomyopathy with unusual involvement of the right ventricle / M. Casanova, C. Gamallo, M. Quero-Jimenes et al. // Eur. J. Cardiol. - 1979. - Vol. 9. - P. 145-149.
Charron, P. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes (see comments) / P. Charron et al. // Eur. Heart J. - 1998. - Vol. 19, № l.-P. 139-145.
Clark, G.E. Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis / G.E. Clark, W.N. Henry, S.E. Epstain // N. Eng. J. Med. - 1987. - Vol. 316. - P. 289-709.
Epstein, N.D. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu-Val mutation and a 403Arg-Gln mutation (see comments) / N.D. Epstein et al. // Circulation. - 1992. - Vol. 86, № 2. - P. 345-352.
Fananapazir, L. Advances in molecular genetics and management of hypertrophic cardiomyopathy (clinical conference) [published erratum appears in JAMA 1999 Dec. 22-29; 282 (24): 2303] (see comments) / L. Fananapazir // JAMA. - 1999. - Vol. 281, № 18. - P. 1746-1752.
Fay, W.P. Natural history of hypertrophic cardiomyopathy in the elderly / W.P. Fay, C.P. Taliercio, D.M. Ilstrup et al. // J. Amer. Coll. Cardiol. - 1990.-Vol. 16. - P. 821-826.
Gaasch, W.H. Left ventricular compliance mechanisms and clinical implications / W.H. Gaasch, H.J. Levine et al. // Ibid. - 1976. - Vol. 38. - P. 645-665.
Gilligan, D.M. / D.M. Gilligan, W.L. Chan, J. Joshi et al. // J. Amer. Coll. Cardiol. - 1993. - Vol. 2l.-P. 1672-1679.
Marian, A.J. Development of the left ventricle hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-bmding protein С gene mutations / A.J. Marian, R.A. Nishimura, S. Cesey // JACC. - 2001. - Vol. 38. - P. 315-321.
Marian, A.J. Resent advances in molecular of hypertrophic cardiomyopathy / A.J. Marian, R. Roberts // Circulation. - 1995. - Vol. 92. - P. 1336-1347.
Marian, A.J. The molecular genetic basis for hypertrophic cardiomyopathy / A.J. Marian, R. Roberts // Cardiovasc. Electrophysiol. - 1998. - Vol. 9. - P. 88-99.
Marian, A.J. The molecular genetic basis for hypertrophic cardiomyopathy / A.J. Marian, R. Roberts // J. Mol. Cel. Cardiol. - 2001. - Vol. 33. - P. 655-670.
Maron, B.J. Hypertrophic cardiomyopathy/ B.J. Maron // Lancet. - 1997. - Vol. 350. - P. 127-133.
Maron, B.J. Hypertrophic cardiomyopathy: a systematic review / B.J. Maron // JAMA. - 1999. - Vol. 281.-P. 650-655.
Maron, B.J. Hypertrophic cardiomyopathy: a systematic review / B.J. Maron // JAMA. - 2002. - Vol. 287.-P. 1308-1320.
Maron, B.J. For the Task Force on Clinical Expert Consensus Documents, Committee for Practice Guidelines, European Society of Cardiology. American College of Cardiology / European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and European Society of Cardiology Committee for Practice Guidelines / B.J. Maron, W.J. McKenna, G.K. Danielson et al. // J. Amer. Coll. Cardiol. - 2003. - Vol. 42. - P. 1687-1713.
Maron, B.J. Impact of laboratory molecular diagnosis on contemporary criteria for genetically transmitted cardiovascular disease: hypertrophic cardiomyopathy, long QT syndrome and Marphan syndrome / B.J. Maron, J.H. Moller, C.E. Seidman et al. // Circulation. - 1998. - Vol. 98. - P. 1460-1471.
Maron, B.J. Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle / B.J. Maron, R.A. Nishimura, Danielson // Ibid. - 1998. -Vol. 98. - P. 2505-2508.
Maron, B.J. Sudden death in hypertrophic cardiomyopathy: a profile in 78 patients / B.J. Maron, W.C. Roberts, S.E. Epstein // Ibid. - 1982. - Vol. 65.-P. 1388-1394.
McCully, B.R. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy / B.R. McCully, A. Rich, R. Nishimura et al. // Ibid. - 1996. - Vol. 94. - P. 467-471.
McKenna, W.J. Prognosis in hypertrophic cardiomyopathy: role of age, and clinical, electrocardiographic and hemodynamic features / W.J. McKenna, J. Deanfield, A. Faruqui et al. // Amer. J. Cardiol. - 1981. - Vol. 47. - P. 532-538.
Niimura, H. Mutations in the gene for cardiac myosin binding protein С on late - onset familial hypertrophic cardiomyopathy / H. Niimura, L.L. Bachinskii et al. // N. Engl. J. Med. - 1998. - Vol. 338. - P. 1248-1257.
Niimura, H. Sarcomere protein gene mutation in hypertrophic cardiomyopathy of the eldery / H. Niimura, К.К. Patton, W.J. McKenna et al. // Circulation. - 2002. - Vol. 105. - P. 446-451.
Ommen, S.R. A physicians guide to the treatment of the hyperthrophic cardiomyopathy/ S.R. Ommen, R.A. Nishimura // Heart Views. - 2000. - Vol. 1. - P. 393-401.
Roberts, R. New concepts in hypertrophic cardiomyopathies. Part II / R. Roberts, U. Sigwart // Circulation. - 2001. - Vol. 104, № 18. - P. 2249-2252.
Seidman, J.G. The genetic basis for cardiomyopathy. From mutation identification to mechanismic paradigms / J.G. Seidman, C.E. Seidman // Cell. - 2001. - Vol. 104. - P. 557-567.
Sherrid, M. Mechanism of benefit of negative inotropes in hypertrophic cardiomyopathy / M. Sherrid, G. Pearle, D.Z. Gusburg // Circulation. - 1998. - Vol. 97. - P. 41-47.
Shoudhury, L. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathies / L. Shoudhury, Mahrhold, A. Wagner et al. // J. Amer. Coll. Cardiol. - 2002 - Vol. 40. - P. 2156-2164.
Shwartz, K. Molecular basis of familial cardiomyopathies / K. Shwartz, L. Carrier et al. // Circulation. - 1995. - Vol. 91. - P. 532-540.
Thierfelder, L. Alfa-tropomyosin and cardiac troponin Т mutation cause familial hypertrophic cardiomyopathy: a disease of the sarcomere / L. Thierfelder, H. Watkins, C. MacRae et al. // Cell. - 1994. - Vol. 77. - P. 701-712.
Wigle E.D. The diagnosis of hypertrophic cardiomyopathy / E.D. Wigle // Неаrt. - 2001. - Vol. 86. - P. 709-714.
Wigle, E.D. Hypertrophic cardiomyopathy. Clinical spectrum and treatment / E.D. Wigle, H. Rakowski, B.P. Kimball et al. // Circulation. - 1995. - Vol. 92. - P. 1680-1692.
Williams, W.G. Results of surgery for idiopathig hypertrophic obstructive cardiomyopathy / W.G. Williams, E.D. Wigle, H. Rakowski et al. // Ibid. - 1987. - Vol. 76. - P. V104-108 (Suppl. V).
